Login / Signup

Insights into Australian optometrists' knowledge and attitude towards prescribing blue light-blocking ophthalmic devices.

Sumeer SinghAndrew J AndersonLaura Elizabeth Downie
Published in: Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) (2019)
Prescribing trends by Australian optometrists in relation to blue light-blocking lenses reflect the inconclusive nature of several aspects of the evidence in this field. Blue light-blocking lens prescribing has increased since 2010, despite practitioners acknowledging the lack of high-quality evidence to support their use and also commonly believing that placebo effects may have a role in patient responses to these lenses. Information from this study will help inform the development of resources to guide evidence-based prescribing of blue light-blocking lens products.
Keyphrases
  • primary care
  • cataract surgery
  • adverse drug
  • light emitting
  • case report
  • emergency department
  • open label
  • phase iii